Syros Pharmaceuticals, Inc.

The current price of SYRS is 4.54 USD — it has decreased by 3.81% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Syros Pharmaceuticals, Inc. stocks are traded under the ticker SYRS.

Syros Pharmaceuticals, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

SYRS stock is 7.27% volatile and has beta coefficient of 0.84. Check out the list of the most volatile stocks — is Syros Pharmaceuticals, Inc. there?

One year price forecast for Syros Pharmaceuticals, Inc. has a max estimate of 37.00 USD and a min estimate of 12.00 USD.

SYRS earnings for the last quarter are −1.43 USD per share, whereas the estimation was −1.14 USD resulting in a −25.44% surprise. The estimated earnings for the next quarter are −1.14 USD per share. See more details about Syros Pharmaceuticals, Inc. earnings.

Syros Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪3.76 M‬ USD despite the estimated figure of ‪3.94 M‬ USD. In the next quarter revenue is expected to reach ‪2.00 M‬ USD.

Yes, you can track Syros Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.

SYRS net income for the last quarter is ‪−64.38 M‬ USD, while the quarter before that showed ‪−40.14 M‬ USD of net income which accounts for −60.39% change. Track more Syros Pharmaceuticals, Inc. financial stats to get the full picture.

Today Syros Pharmaceuticals, Inc. has the market capitalization of ‪124.86 M‬, it has decreased by 2.91% over the last week.

No, SYRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, SYRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Syros Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.

SYRS reached its all-time high on Aug 7, 2017 with the price of 243.75 USD, and its all-time low was 2.09 USD and was reached on Oct 19, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 68.00 employees. See our rating of the largest employees — is Syros Pharmaceuticals, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Syros Pharmaceuticals, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Syros Pharmaceuticals, Inc. stock shows the sell signal. See more of Syros Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Syros Pharmaceuticals, Inc. future price: according to them, SYRS price has a max estimate of 37.00 USD and a min estimate of 12.00 USD. Read a more detailed Syros Pharmaceuticals, Inc. forecast: see what analysts think of Syros Pharmaceuticals, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Syros Pharmaceuticals, Inc. EBITDA is ‪−124.25 M‬ USD, and current EBITDA margin is ‪−1.25 K‬%. See more stats in Syros Pharmaceuticals, Inc. financial statements.